SEC Form 4 · accession 0001193125-26-391740

Pharvaris N.V. · PHVS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President

Period of report

Sep 11, 2026

Accepted (ET)

Sep 15, 2026 · 2:30 pm EDT

Rule 10b5-1 plan

yes — trade under a plan

Issuer CIK

0001830487

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Sep 11, 2026	M	15,000	$2.59	A	80,179	D
Common Stock^F2	Sep 11, 2026	S	15,000	$40.1298	D	65,179	D
Common Stock^F3	Sep 11, 2026	F	109	$37.51	D	65,070	D
Common Stock^F3	Sep 14, 2026	F	117	$38.02	D	64,953	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F4	$2.59	holding	—	—	—	—	Feb 3, 2030	Common Stock	15,000	13,308	D

F1This is a scheduled exercise and sale from 10b5-1 trading plan.
F2The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $40.00 to $40.30. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3Represents shares withheld by the issuer to satisfy tax withholding obligations upon the vesting of restricted stock units.
F425% of the option vested on February 3, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter.